To include your compound in the COVID-19 Resource Center, submit it here.

Chiron beats Street EPS estimate

CHIR reported second quarter EPS of $0.29, which beat the Street's estimate by

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE